Subgroup analyses in randomized clinical trials: value and limitations. Review #3 on important aspects of randomized clinical trials in cardiovascular pharmacotherapy

1. Drexel, H.
2. Pocock, S.J.
3. Lewis, B.S.
4. Saely, C.H.
5. Kaski, J.C.
6. Rosano, G.M.C.
7. Tautermann, G.
8. Huber, K.
9. Dopheide, J.F.
10. Mader, A.
11. Niessner, A.
12. Savarese, G.
13. Schmidt, T.A.
14. Semb, A.G.
15. Tamargo, J.
16. Wassmann, S.
17. Clodi, M.
18. Kjeldsen, K.P.
19. Agewall, S.